Baker Bros. Advisors LP Celldex Therapeutics, Inc. Transaction History
Baker Bros. Advisors LP
- $7.52 Billion
- Q2 2024
A detailed history of Baker Bros. Advisors LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 247,644 shares of CLDX stock, worth $7.36 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
247,644
Previous 247,644
-0.0%
Holding current value
$7.36 Million
Previous $10.4 Million
11.82%
% of portfolio
0.12%
Previous 0.13%
Shares
1 transactions
Others Institutions Holding CLDX
# of Institutions
196Shares Held
63.5MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$240 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$139 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$111 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$101 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$98.9 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.39B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...